Summary

Overview
The Brazil mammography market reached US$ 64.63 million in 2023 and is expected to reach US$ 101.45 million by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031.
Mammography is medical imaging Application based on X-ray imaging technlogy. It is used to generate image of breast, which is used to diagnose and screening of cancerous cells. There are majorly two types of mammography devices which include 2D mammography, 3D mammography also known and breast tomosynthesis or digital mamography.
The rising prevelance of breast cancer, increased awareness campaigns and screening programs are the major growth driving factors for mammography market in Brazil.
Market Dynamics: Drivers
Rising prevalence of breast cancer
The rising prevalence of breast cancer in Brazil is one of the major driver for mamography market in the forecast period. Breast cancer represents a major malignancy in women, accounting for approximately 30.8% all cases in Brazil. For instance, according to the World Health Organization (WHO) Global Cancer Observatory statistics, the incident cases of breast cancer in Brazil stood at 94.7 thousand in 2022. This incidence is expected to rise and reach 100.4 thousand cases in 2025 and 111.6 thousand in 2030.
This rising incidence of cancer can create a demand for diagnostic procedures such as mammography which is considered as a gold standard procedure. This device can be used for early cancer detection, diagnosis, and assessing the prognosis of breast cancer in response to various therapeutic modalities. As the number of cancer cases rises, the demand for advanced mammography devices is anticipated to rise.
Restraints
Lack of government investments to increase the breast cancer screening coverage is one of the major restraining factor for mammography market growth in Brazil. Moreover, lack of proper access to healthcare, and limited availability of mammography devices in remote parts of the country, may also restrain the market growth.
For more details on this report - Request for Sample
Segment Analysis
The Brazil mammography market is segmented based on type, application, and end-users.
3D mammography in the type segment accounted for approximately 56.4% of the Brazil mammography market share
3D mammography also known as tomsynthesis is currently the widely accepted diagnostic method for breast cancer. Tomosynthesis generates 3D images of the breast tissue, which come of best use when detecting the cancers at early stage, and also to record the prognosis. It offers much more advanced images as compared to 2D or traditional mammograms. Moreover, the chances of a false-positive is much less even in dense breast tissue.
Since its approval in 2011 by the U.S. Food and Drug Administration (FDA), it has become a standard approach for breast cancer screening. Majority of the healthcare facilities are replacing traditional mamograms with advanced 3D mammograms. Moreover, tomosynthesis generate lower X-ray radiation as compared to traditional mammography, creating another reason for its rising adoption. This is particularly helpful for patients who have recurrent breast cancer causing less damage due to radiation even after repeated exposure.
Market Segmentation
By Type
• 2D Mammography
• 3D Mammography
By Application
• Cancer Screening
• Cancer Diagnosis
By End-Users
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others
Competitive Landscape
The major players in the mammography market include FUJIFILM do Brasil Ltda., GE HealthCare., Siemens Healthcare Diagnostics Ltd., PLANMED OY, Carestream Health., DRTECH, Metaltronica S.p.A., Hologic, Inc., DMS Group and Agfa-Gevaert Group. among others.
Why Purchase the Report?
• To visualize the Brazil mammography market segmentation based on type, application, and end-users as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of mammography market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Brazil mammography market report would provide approximately 39 tables, 25 figures, and 187 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-Users
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising prevalence of breast cancer
4.1.1.2. Rising awareness campaigns and screening programs
4.1.2. Restraints
4.1.2.1. Limited availability of mammography devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. 2D Mammography*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. 3D Mammography
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Cancer Screening*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cancer Diagnosis
8. By End-Users
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
8.1.2. Market Attractiveness Index, By End-Users
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Diagnostic Centers
8.5. Others
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. FUJIFILM do Brasil Ltda.*
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. GE HealthCare.
10.3. Siemens Healthcare Diagnostics Ltd.
10.4. PLANMED OY
10.5. Carestream Health.
10.6. DRTECH
10.7. Metaltronica S.p.A.
10.8. Hologic, Inc.
10.9. DMS Group
10.10. Agfa-Gevaert Group.
LIST NOT EXHAUSTIVE
11. Appendix
11.1. About Us and Services
11.2. Contact Us